Brought to you by 
Boston Scientific invests in Intelect, gets DBS rights
25 Nov 2008
Executive Summary
Boston Scientific has received a co-exclusive license to neuromodulation company Intelect Medical's Dimension software technology. Along with fellow Series B investor Greatbatch, Boston Scientific has also agreed to buy $11-13.5mm in Intelect common stock, and the two companies may buy additional equity in the future. (This financing for Intelect is considered a Series B extension.)
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
Deal Status
- Final
Deal Type
-
Alliance
- Includes Equity
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Boston Scientific invests in Intelect, gets DBS rights
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice